Drug Treatment Services
-
Manufactured by UroTechbased in USA
Taking medications to counteract the condition causing the stone to ...
-
Manufactured by Fab’entechbased in FRANCE
Due to their immediate neutralising action, Fab’entech’s polyclonal antibodies can be used to design therapies that are well suited to the management and treatment of drug ...
-
based in ITALY
The Pharmacovigilance system collects and studies adverse events (=noxious) which may be associated to a drug treatment, in order to assess their incidence. identify the cause-effect relationship with the use of the drug. identify any possible risk factors for the occurrence of such adverse events. identify possible means for the ...
-
based in SPAIN
Whether you are a small or a large pharmaceutical company, a CRO, an academic institution or a research center, you can benefit from our 3D-SHAPER® data analysis service of bone densitometry (DXA) scans. Our service uses 3D-Shaper Technology. It allows you to analyze in 3D the effects of drug treatments on the cortical and trabecular bone ...
-
by iFyber, LLCbased in USA
Biomarkers are measurable substances in an organism whose presence can be indicative of a disease state, infection, or environmental exposure. This detectable response can vary based on the specific medical intervention and may give clues regarding disease progression, wound healing, or the physiological side-effects of a device or drug ...
-
Manufactured by Hebei Lingding Biotechnology Co., Ltd.based in CHINA
molecule and represents a new class of drugs for the treatment of type 2 diabetes. Tirzepatide is a dual glucose-dependent insu'linotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insu'linotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately ...
-
Manufactured by Hebei Lingding Biotechnology Co., Ltd.based in CHINA
molecule and represents a new class of drugs for the treatment of type 2 diabetes. Tirzepatide is a dual glucose-dependent insu’linotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insu‘linotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately ...
-
Manufactured by HemoShear Therapeutics, Inc.based in USA
Using our powerful REVEAL-TxTM drug discovery platform, our scientists are identifying and validating promising approaches to develop novel treatments aiming to extend and improve the quality of life of patients with rare diseases. In our most advanced program, the company is conducting a phase 2 clinical trial of HST5040, an oral small ...
-
Manufactured by Creative Biolabsbased in CHINA
is essential for homeostasis. Any malfunction of key enzymes (mutation, overproduction, underproduction or deletion) can lead to diseases. Therefore, enzymes have long been considered as important drug targets for the treatment of major human ...
-
Manufactured by Neuron Biobased in SPAIN
Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops ...
-
by Natera, Inc.based in USA
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP ...
-
Manufactured by MediTECH Electronic GmbHbased in GERMANY
The decision on whether a person has ADHD/ADHD has so far been based mainly on questionnaires and behavioural observation. Both methods are highly subjective. In cooperation with the Charité Berlin and the University Clinic Mainz, MediTECH has developed a new objective measurement procedure for the determination / exclusion of ...
-
based in USA
Antibiotic resistance is an escalating global crisis, where the spread of drug resistance is outpacing the development of new ...
-
Manufactured by BrainXellbased in USA
BrainXell provides custom service to fit your research goals. Our scientific expertise, flexible production paradigms, and individual attention to customer projects allow us to tailor a project plan that meets necessary timelines and deliverables. ...
-
Manufactured by Cloud-Clone Corp.based in USA
The development of human disease is very complex, to itself as experimental object to in-depth study of the mechanism of disease, the accumulation of clinical experience not only in time and space are limited and many experiments on the moral are restricted. Animal models can provides the basic platform for the study of safety research of ...
-
based in USA
CTEH®’s pharmacology & toxicology professionals have extensive experience assessing the human toxicity of drugs and chemicals, and drug interactions and adverse reactions. CTEH® provides additional experience in pharmacokinetic analysis. Levels of drugs or chemicals in blood and/or urine are frequently key pieces of ...
-
by OracleBiobased in UNITED KINGDOM
Fast turnaround, accurate data; enabling you to move forward with confidence. Quantitative Digital Pathology provides detailed cell by cell data to enhance decision making in NASH & Fibrosis research. Our dedicated team of image analysis scientists have extensive experience in the accurate quantification of fibrosis, steatosis and inflammation. ...
-
Manufactured by Destiny Pharma plcbased in UNITED KINGDOM
Work on earlier programmes investigating infections in areas such as respiratory, dermal, ocular and biofilms carries on as research projects, including academic and/or commercial collaborations and grant funded ...
-
Manufactured by MODAG GmbHbased in GERMANY
Multiple System Atrophy (MSA) is a rare neurodegenerative disorder that belongs to the group of synucleinopathies and is also classified as an “atypical parkinsonism” disorder. Pathologically, MSA is characterized by abnormal deposits of the α-synuclein protein mainly in oligodendroglial cells and also in certain nerve cells. Typically, there is a dysfunction of the autonomic ...
-
by elminda Ltd.based in ISRAEL
, assisting in understanding drug mechanism, identifying placebo effects, mapping cognitive functions, serving as a screening tool, identifying subtypes and treatment protocol success and failure likelihood ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you